The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar
SYDNEY, AU, Feb 15, 2023 ̵ […]
SinoHytec Successfully Listed on the Main Board of HKEX
HONG KONG, Jan 12, 2023 – […]
Research commenced with Keio University to discover drugs using “Chemicals Informatics”
TOKYO, Jan 12, 2023 – (J […]
Novotech Acquires US-based Drug Development Consulting Firm, CBR International
SINGAPORE, Jan 12, 2023 – […]
HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations
ROCKVILLE, MD and SHENZHEN, CH […]
The best of the best real estate developers, projects prevail at 17th PropertyGuru Asia Property Awards Grand Final
BANGKOK, THAILAND, Dec 10, 202 […]
Japan, United Kingdom and Italy Formally Announce Joint Development of a Next-Generation Fighter
TOKYO, Dec 9, 2022 – (JC […]
Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials
SYDNEY, AU, Dec 6, 2022 – […]
IBO Technology Announces 2022 Interim Results
HONG KONG, Nov 30, 2022 – […]
Pertamina, ExxonMobil agree to develop CCS for decarbonization
JAKARTA, Nov 15, 2022 – […]
Grand Ming Group Holdings Limited Announces Interim Results for the Six Months Ended 30 September 2022
HONG KONG, Nov 12, 2022 – […]
Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy
SYDNEY, AU, Nov 11, 2022 ̵ […]
SinoMab Announces Appointment of Mr. Shanchun WANG as the President (China) of the Company
HONG KONG, Nov 4, 2022 – […]
ONERHT partners Democratic Republic of Congo for sustainable economic development and growth
SINGAPORE, Oct 25, 2022 – […]
Clinical Research Opportunities in China and the Path to USFDA Approval – Whitepaper
SYDNEY, AU, Oct 25, 2022 ̵ […]
The Biotech Landscape Webinar: Market Trends, Priorities, Predictions, and Pathways to FDA Approval
SYDNEY, AU, Oct 17, 2022 ̵ […]
